The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome

    July 2023 in “ Journal of Clinical Medicine ”
    Alekya Devi Anala, Insiya Sajjad Hussain Saifudeen, Maryam Ibrahim … Stephen L. Atkin
    Studysummary This study reviews current treatments for PCOS and evaluates Tirzepatide as a potential option for its management, suggesting possible benefits for those with obesity and metabolic syndrome but not for those of normal weight.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 10

    1. Hyperandrogenism in Polycystic Ovarian Syndrome and Role of CYP Gene Variants: A Review Egyptian Journal of Medical Human Genetics · 2019
    2. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies Clinical medicine insights · 2019
    3. Polycystic Ovary Syndrome (PCOS): An Inflammatory, Systemic, Lifestyle Endocrinopathy Journal of steroid biochemistry and molecular biology/˜The œJournal of steroid biochemistry and molecular biology · 2018
    4. Ethnicity, Obesity, and the Prevalence of Impaired Glucose Tolerance and Type 2 Diabetes in PCOS: A Systematic Review and Meta-Regression Human Reproduction Update · 2018
    5. Nonalcoholic Fatty Liver Disease and Polycystic Ovary Syndrome World Journal of Gastroenterology · 2014
    6. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology and Metabolism · 2013
    7. Lifestyle Changes in Women with Polycystic Ovary Syndrome Cochrane library · 2011
    8. Polycystic Ovary Syndrome: A Complex Condition with Psychological, Reproductive, and Metabolic Manifestations That Impacts Health Across the Lifespan BMC Medicine · 2010
    9. Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity Mediators of Inflammation · 2010
    10. Polycystic Ovary Syndrome: Symptoms, Causes, and Risks JAMA · 2007